Goldman Sachs Group Inc Selecta Biosciences Inc Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,180,043 shares of SELB stock, worth $991,236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,180,043
Previous 1,487,000 20.64%
Holding current value
$991,236
Previous $1.03 Million 3.41%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.62 - $0.85 $190,313 - $260,913
-306,957 Reduced 20.64%
1,180,043 $991,000
Q4 2023

Feb 13, 2024
BUY
$0.67 - $1.35 $99,649 - $200,786
148,731 Added 11.11%
1,487,000 $1.03 Million
Q3 2023

May 14, 2024
SELL
$1.02 - $1.23 $151,705 - $182,939
-148,731 Reduced 10.0%
1,338,269 $1.42 Million
Q3 2023

Nov 14, 2023
SELL
$1.02 - $1.23 $74,061 - $89,309
-72,609 Reduced 5.15%
1,338,269 $1.42 Million
Q2 2023

May 14, 2024
BUY
$1.04 - $1.4 $1.07 Million - $1.44 Million
1,025,164 Added 265.78%
1,410,878 $1.58 Million
Q2 2023

Aug 14, 2023
BUY
$1.04 - $1.4 $1.07 Million - $1.44 Million
1,025,164 Added 265.78%
1,410,878 $1.58 Million
Q1 2023

May 14, 2024
BUY
$1.15 - $1.89 $353,710 - $581,314
307,574 Added 393.62%
385,714 $536,000
Q1 2023

May 11, 2023
BUY
$1.15 - $1.89 $353,710 - $581,314
307,574 Added 393.62%
385,714 $536,000
Q4 2022

May 14, 2024
SELL
$0.96 - $1.6 $69,012 - $115,020
-71,888 Reduced 47.92%
78,140 $88,000
Q4 2022

Feb 13, 2023
SELL
$0.96 - $1.6 $69,012 - $115,020
-71,888 Reduced 47.92%
78,140 $88,000
Q3 2022

May 14, 2024
SELL
$1.33 - $2.6 $149,808 - $292,858
-112,638 Reduced 42.88%
150,028 $246,000
Q3 2022

Nov 10, 2022
SELL
$1.33 - $2.6 $149,808 - $292,858
-112,638 Reduced 42.88%
150,028 $0
Q2 2022

May 14, 2024
SELL
$0.67 - $1.4 $820,303 - $1.71 Million
-1,224,334 Reduced 82.34%
262,666 $344,000
Q2 2022

Aug 15, 2022
SELL
$0.67 - $1.4 $600,715 - $1.26 Million
-896,591 Reduced 77.34%
262,666 $344,000
Q1 2022

May 16, 2022
SELL
$1.23 - $3.31 $82,464 - $221,915
-67,044 Reduced 5.47%
1,159,257 $1.43 Million
Q4 2021

Feb 14, 2022
SELL
$2.89 - $4.43 $202,406 - $310,263
-70,037 Reduced 5.4%
1,226,301 $4 Million
Q3 2021

Nov 10, 2021
BUY
$3.36 - $4.62 $4.36 Million - $5.99 Million
1,296,338 New
1,296,338 $5.39 Million

Others Institutions Holding SELB

# of Institutions
68
Shares Held
41.4M
Call Options Held
16.8K
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email